180 related articles for article (PubMed ID: 32819560)
1. BAP1 regulates AMPK-mTOR signalling pathway through deubiquitinating and stabilizing tumour-suppressor LKB1.
Yang C; Ding H; Yang Y; Yang L; Yang Y; Fang M; Ren J; Hu R; Wang C; Geng W
Biochem Biophys Res Commun; 2020 Sep; 529(4):1025-1032. PubMed ID: 32819560
[TBL] [Abstract][Full Text] [Related]
2. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Shaw RJ
Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
[TBL] [Abstract][Full Text] [Related]
3. Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.
Huang X; Wullschleger S; Shpiro N; McGuire VA; Sakamoto K; Woods YL; McBurnie W; Fleming S; Alessi DR
Biochem J; 2008 Jun; 412(2):211-21. PubMed ID: 18387000
[TBL] [Abstract][Full Text] [Related]
4. A comparison of LKB1/AMPK/mTOR metabolic axis response to global ischaemia in brain, heart, liver and kidney in a rat model of cardiac arrest.
Majd S; Power JHT; Chataway TK; Grantham HJM
BMC Cell Biol; 2018 Jun; 19(1):7. PubMed ID: 29921218
[TBL] [Abstract][Full Text] [Related]
5. mTOR remains unchanged in diet-resistant (DR) rats despite impaired LKB1/AMPK cascade in adipose tissue.
Han J; Liang H; Tian D; Du J; Wang Q; Xi P; Wang H; Li Y
Biochem Biophys Res Commun; 2016 Aug; 476(4):333-339. PubMed ID: 27235551
[TBL] [Abstract][Full Text] [Related]
6. The deubiquitinase USP10 mediates crosstalk between the LKB1/AMPK axis and Wnt/β-catenin signaling in cancer.
Wang Y; Liu J; Zheng S; Cao L; Li Y; Sheng R
FEBS Lett; 2023 Dec; 597(24):3061-3071. PubMed ID: 37873736
[TBL] [Abstract][Full Text] [Related]
7. The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma.
Chua V; Han A; Bechtel N; Purwin TJ; Hunter E; Liao C; Harbour JW; Aplin AE
Pigment Cell Melanoma Res; 2022 Jan; 35(1):78-87. PubMed ID: 34347929
[TBL] [Abstract][Full Text] [Related]
8. Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.
Jung TY; Ryu JE; Jang MM; Lee SY; Jin GR; Kim CW; Lee CY; Kim H; Kim E; Park S; Lee S; Lee C; Kim W; Kim T; Lee SY; Ju BG; Kim HS
Exp Mol Med; 2020 Nov; 52(11):1831-1844. PubMed ID: 33219302
[TBL] [Abstract][Full Text] [Related]
9. A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway.
Hsu JL; Liu SP; Lee CC; Hsu LC; Ho YF; Huang HS; Guh JH
Naunyn Schmiedebergs Arch Pharmacol; 2014 Oct; 387(10):979-90. PubMed ID: 25005758
[TBL] [Abstract][Full Text] [Related]
10. The Lkb1 metabolic sensor maintains haematopoietic stem cell survival.
Gurumurthy S; Xie SZ; Alagesan B; Kim J; Yusuf RZ; Saez B; Tzatsos A; Ozsolak F; Milos P; Ferrari F; Park PJ; Shirihai OS; Scadden DT; Bardeesy N
Nature; 2010 Dec; 468(7324):659-63. PubMed ID: 21124451
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitination and Activation of AMPK by USP10.
Deng M; Yang X; Qin B; Liu T; Zhang H; Guo W; Lee SB; Kim JJ; Yuan J; Pei H; Wang L; Lou Z
Mol Cell; 2016 Feb; 61(4):614-624. PubMed ID: 26876938
[TBL] [Abstract][Full Text] [Related]
12. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN.
Deng R; Guo Y; Li L; He J; Qiang Z; Zhang H; Chen R; Wang Y; Zhao X; Yu J
Mol Oncol; 2021 Jan; 15(1):279-298. PubMed ID: 33155366
[TBL] [Abstract][Full Text] [Related]
13. Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis.
Tanwar PS; Kaneko-Tarui T; Zhang L; Teixeira JM
Hum Mol Genet; 2012 Oct; 21(20):4394-405. PubMed ID: 22791749
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells.
Dong LX; Sun LL; Zhang X; Pan L; Lian LJ; Chen Z; Zhong DS
Acta Pharmacol Sin; 2013 Feb; 34(2):314-8. PubMed ID: 23178462
[TBL] [Abstract][Full Text] [Related]
15. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
[TBL] [Abstract][Full Text] [Related]
16. Metformin impairs the growth of liver kinase B1-intact cervical cancer cells.
Xiao X; He Q; Lu C; Werle KD; Zhao RX; Chen J; Davis BC; Cui R; Liang J; Xu ZX
Gynecol Oncol; 2012 Oct; 127(1):249-55. PubMed ID: 22735790
[TBL] [Abstract][Full Text] [Related]
17. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells.
Nakada D; Saunders TL; Morrison SJ
Nature; 2010 Dec; 468(7324):653-8. PubMed ID: 21124450
[TBL] [Abstract][Full Text] [Related]
18. LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap.
Nguyen HB; Babcock JT; Wells CD; Quilliam LA
Oncogene; 2013 Aug; 32(35):4100-9. PubMed ID: 23027127
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.
Zu Y; Liu L; Lee MY; Xu C; Liang Y; Man RY; Vanhoutte PM; Wang Y
Circ Res; 2010 Apr; 106(8):1384-93. PubMed ID: 20203304
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]